Close up of the Novartis logo on the Banting 1 building, Novartis Campus Basel. (Novartis) “As a Swiss-based company with a significant presence in the U.S., these investments will enable us to ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s tariffs on imports.